In the equity raising presentation 14/3
On the funding PYC through multiple milestones page in small writing it says establishing human safety in ADOA allows multiple concurrent phase 2 studies (eg. Glaucoma) in small writing down the bottom
I thought that was interesting multiple concurrent phase 2 studies sounds like a good thing?
Eagle
In the equity raising presentation 14/3On the funding PYC...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
0.010(0.87%) |
Mkt cap ! $673.6M | |||
| Open | High | Low | Value | Volume |
| $1.16 | $1.17 | $1.16 | $18.84K | 16.23K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 579 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 7566 | 3 |
View Market Depth
| Last trade - 11.08am 23/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |